Patients with valvular heart disease were satisfied with transcatheter aortic valve replacement (TAVR) and many made their treatment decisions with returning to active living in mind, according to a survey released by a patient advocacy group. In the survey, conducted by the patient group heart-valve-surgery.com and supported in part by Medtronic, 98% of those who underwent TAVR said they were satisfied with it, and 49% said returning to active living was a major factor in their treatment decision.
|